• Business Development
  • CSR
  • Adverse Event Reporting


Cancer is the disease which is characterized by uncontrolled cell growth and in some cases it may metastasize (spread to the body). Cancer is the deadliest disease and this requires immediate attention of doctor. Despite of availability of number of anticancer drugs (oncology drugs) available for cancer cure, still much more is needed to be discovered.

Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer. Alkem has dedicated division for anticancer products, it is Cytomed division. Cytomed division is serving the need of cancer medication to Indian cancer patients since last 14 years. As far as anticancer medicines are concerned Alkem Cytomed has hormonal preparations, cytotoxic drugs and targeted therapeutic drugs in its product basket.

Alkem recently entered into the era of bio similar drugs by launching Rituximab (Cytomab) which is a monoclonal antibody. Monoclonal antibody is the novel targeted therapy and the most advanced form of drugs which are used to cure or to stop complicated chronic diseases. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).

Enzene Biosciences a dedicated research unit of Alkem laboratories is currently working on number of monoclonal antibodies. Several other bio similar drugs are in pipeline and soon will be available for the affordable cure of Indian patients.